Please use this identifier to cite or link to this item:
Authors: Krajnak, Slavomir
Jäkel, Jörg
Anić, Katharina
Schwab, Roxana
Schmidt, Marcus
Hasenburg, Annette
Roth, Wilfried
Brenner, Walburgis
Battista, Marco Johannes
Title: Role of integrins in the metastatic spread of high-grade serous ovarian cancer
Online publication date: 4-Aug-2022
Year of first publication: 2022
Language: english
Abstract: Purpose Integrins may be involved in the metastatic spread of high-grade serous ovarian cancer (HGSOC) which determines the therapeutical approach and prognosis. We investigated the integrin expression in primary tumor and metastases of advanced HGSOC. Methods The expression of integrin α2, α4, α5, α6, and β1 was assessed by immunostaining in tumor samples of the ovary, omentum, and peritoneum of each patient. Differences in integrin expression among tumor localizations and their association with clinicopathological parameters were examined by Fisher’s exact test. The impact of integrin expression on progression-free survival (PFS) and overall survival (OS) was examined by Cox regression and Kaplan–Meier analyses. Results Hundred and thirteen tumor samples of 40 HGSOC patients were examined. The expression of the integrins did not differ between the three tumor localizations (all p values > 0.05) with the exception of high expression of integrin α4 in primary tumor and omentum (52.5% versus 47.5%, p = 0.008) and primary tumor and peritoneum (52.5% versus 47.5%, p = 0.050). High expression of integrin α4 in peritoneum was associated with poorer PFS (HR 2.02 95% CI 1.01–4.05, p = 0.047), younger age (p = 0.047), and death (p = 0.046). Median PFS in patients with high expression of integrin α4 was 13.00 months, whereas median PFS in patients without high expression of integrin α4 was 21.00 months (p = 0.040). Expression of other integrins did not correlate with PFS or OS. Conclusion Expression of integrin α4 may be altered during the metastatic spread of HGSOC and affect prognosis, whereas expression of integrin α2, α5, α6, and β1 did not reveal any prognostic value.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
Version: Published version
Publication type: Zeitschriftenaufsatz
License: CC BY
Information on rights of use:
Journal: Archives of gynecology and obstetrics
Pages or article number: 1291
Publisher: Springer
Publisher place: Berlin u.a.
Issue date: 2022
ISSN: 1432-0711
Publisher DOI: 10.1007/s00404-021-06281-7
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
role_of_integrins_in_the_meta-20220801120419305.pdf1.04 MBAdobe PDFView/Open